NCT02034032View on ClinicalTrials.gov

Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to TKA

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions
Knee Osteoarthritis
Interventions
PROCEDURE

Regenexx SD

stem cell treatment

BEHAVIORAL

Exercise Therapy

exercise therapy control

Trial Locations (1)

60016

Regenerative Pain Center; Weil Foot, Ankle and Orthopedic Institute, Des Plaines

All Listed Sponsors
lead

Regenexx, LLC

INDUSTRY

NCT02034032 - Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to TKA | Biotech Hunter | Biotech Hunter